2022-09-12T14:55:30-05:00 2021-12-31 411360831 OLSEN THIELEN & CO LTD 2675 LONG LAKE ROAD ST PAUL MN 55113 990 2021-01-01 850342069 NORTH AMERICAN NEURO-OPHTHALMOLOGY SOCIETY NORT 9526462047 1935 COUNTY ROAD B2 W 165 ROSEVILLE MN 55113 TOMA OSSIAN EXECUTIVE DIRECTOR 9526462047 2022-08-24 1 TOMA OSSIAN 999009999 RYAN VETTRUS CPA P01243596 6514834521 3 AAL1 IAL1 2021 2023-04-26 12:10:37Z X VALERIE BIOUSSE MD 1935 COUNTY ROAD B2 W 165 ROSEVILLE MN 55113 1079011 0 X WWW.NANOSWEB.ORG X 1986 NM EXCELLENCE IN PATIENT CARE THROUGH EDUCATION, RESEARCH & THE PRACTICE OF NEURO-OPHTHALMOLOGY. 13 11 0 200 0 0 35260 61116 1010580 918159 54696 74550 15809 25186 1116345 1079011 25000 30000 0 0 0 0 0 0 0 1101023 734350 1126023 764350 -9678 314661 2412591 2976357 347820 492200 2064771 2484157 X DEDICATED TO THE ACHIEVEMENT OF EXCELLENCE IN PATIENT CARE THROUGH THE SUPPORT AND PROMOTION OF EDUCATION, COMMUNICATION, RESEARCH, AND THE PRACTICE OF NEURO-OPHTHALMOLOGY. 0 0 394205 30000 800796 THE NORTH AMERICAN NEURO-OPHTHALMOLOGY SOCIETY (NANOS) IS THE ONLY ORGANIZATION DEDICATED TO THE ADVANCEMENT OF NEURO-OPHTHALMOLOGIC EDUCATION AND INFORMATION IN NORTH AMERICA. IN FEBRUARY 2021, NANOS SPONSORED ITS 47TH ANNUAL MEETING, OUR FIRST VIRTUAL MEETING DUE TO THE PANDEMIC. THE EDUCATIONAL MEETING INCLUDES SEMINARS, WORKSHOPS, HANDS-ON TRAINING, PLATFORM PRESENTATIONS, AND DISCUSSION OF CASES AND BEST PRACTICES IN NEURO-OPHTHALMIC RESEARCH, BASIC SCIENCE, AND PATIENT CARE. THE SOCIETY HAS ITS OWN JOURNAL, THE JOURNAL OF NEURO-OPHTHALMOLOGY, AND MAINTAINS A WEB PAGE THAT INCLUDES AN E-MAIL SCIENTIFIC DISCUSSION GROUP.NANOS USES MULTIPLE DATA SOURCES TO MEASURE THE IMPACT OF ITS EDUCATIONAL ACTIVITIES ON LEARNERS AND ON THE DISCIPLINE OF NEURO-OPHTHALMOLOGY. THESE MEASURES REFLECT PROFESSIONALS' NEED TO EXAMINE CURRENT PRACTICES, EVALUATE THE APPROPRIATENESS OF EDUCATIONAL ACTIVITIES IN ORDER TO IMPROVE THEIR LEVELS OF KNOWLEDGE OF NEURO-OPHTHALMOLOGY BASIC SCIENCE AND CLINICAL PRACTICE, COMPETENCE IN DIAGNOSING AND TREATING NEURO-OPHTHALMIC DISEASE, AND PERFORMANCE IN DIAGNOSING AND TREATING NEURO-OPHTHALMIC DISEASES.THE SOCIETY RECOGNIZES OUTSTANDING WORK AND PROVIDES BEST ABSTRACT AWARDS FOR PLATFORM AND POSTER PRESENTATIONS AT THE ANNUAL MEETING BY A RESIDENT, STUDENT OR FELLOW. THE SOCIETY GIVES A DISTINGUISHED SERVICE AWARD AT THE DISCRETION OF THE EXECUTIVE BOARD TO THOSE WHO HAVE PROVIDED A SUSTAINED AND SUBSTANTIAL SERVICE TO THE NORTH AMERICAN NEURO-OPHTHALMOLOGY SOCIETY.NANOS GIVES A YOUNG INVESTIGATOR AWARD. THIS AWARD WAS ESTABLISHED TO ENCOURAGE AND RECOGNIZE BASIC OR CLINICAL RESEARCH IN NEURO-OPHTHALMOLOGY BY A NANOS CANDIDATE OR ACTIVE MEMBER. THE ORIGINALITY, SCIENTIFIC MERIT AND NEURO-OPHTHALMIC INTEREST OF A DEVELOPING INVESTIGATOR'S TOTAL BODY OF WORK COMBINED WITH A REPRESENTATIVE NEW RESEARCH MANUSCRIPT WILL BE CONSIDERED AS CRITERIA TO DETERMINE THE AWARD RECIPIENT.NANOS RECOGNIZES THE NEED TO STIMULATE INVESTIGATOR-INITIATED RESEARCH PROGRAMS IN NEURO-OPHTHALMOLOGY. THE NANOS PILOT RESEARCH GRANT PROGRAM PROVIDES A ONE-YEAR, NON-RENEWABLE SOURCE OF FUNDING TO HELP PRINCIPAL INVESTIGATORS GENERATE PRELIMINARY DATA THAT WILL LEAD TO ADDITIONAL FUNDING FROM OTHER NATIONAL AGENCIES OR FOUNDATIONS.NANOS RECOGNIZES THE NEED TO STIMULATE LEADERSHIP DEVELOPMENT IN DIVERSE MEMBERS OF ITS COMMUNITY. THE DR. IVY DREIZIN LEADERSHIP DEVELOPMENT GRANT PROVIDES A ONE-TIME, NON-RENEWABLE SOURCE OF FUNDING TO SUPPORT LEADERSHIP DEVELOPMENT FOR A NANOS MEMBER. PRIORITY IS GIVEN TO THOSE WHO HAVE BEEN ACTIVELY INVOLVED IN THE WOMEN IN NEURO-OPHTHALMOLOGY COMMITTEE AND NANOS. NOMINEES AND ALTERNATES ARE SELECTED BY THE WOMEN IN NEURO-OPHTHALMOLOGY STEERING COMMITTEE, SUBJECT TO APPROVAL BY THE NANOS BOARD OF DIRECTORS. 394205 1 1 0 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 16 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 13 11 1 1 1 0 1 1 1 1 1 0 0 1 1 1 1 0 1 0 0 0 MN X GLOBAL MANAGEMENT PARTNERS LLC 9526462030 1935 COUNTY ROAD B2 W STE 165 ROSEVILLE MN 55113 X VALERIE BIOUSSE MD PRESIDENT 2.00 X X 0 0 0 PREM S SUBRAMANIAN MD PHD PRESIDENT ELECT 2.00 X X 0 0 0 PETER A QUIROS MD VICE PRESIDENT 2.00 X X 0 0 0 JANET RUCKER MD SECRETARY 2.00 X X 0 0 0 LARRY FROHMAN MD TREASURER/EXECUTIVE VP 2.00 X X 0 0 0 NANCY J NEWMAN MD SENIOR VP NEURO-OPHTHALMIC EDUCATION 2.00 X X 0 0 0 MARK L MOSTER MD SENIOR VP NEURO-OPHTHALMIC ADVOCAY & PRACTICE 2.00 X X 0 0 0 ANDREW G LEE MD IMMEDIATE PAST PRESIDENT 2.00 X 0 0 0 JOHN CHEN MD BOARD MEMBER 2.00 X 0 0 0 LYNN GORDON MD PHD BOARD MEMBER 2.00 X 0 0 0 HEATHER E MOSS MD PHD BOARD MEMBER 2.00 X 0 0 0 MELISSA W KO MD BOARD MEMBER 2.00 X 0 0 0 KEVIN LAI MD BOARD MEMBER 2.00 X 0 0 0 LAURA BALCER MD EDITOR OF THE JOURNAL OF NEURO-OPHTHALMOLOGY 2.00 X 0 0 0 TOMA OSSIAN CMP EXECUTIVE DIRECTOR 22.00 X 0 0 0 0 0 0 0 0 0 0 GLOBAL MANAGEMENT PARTNERS LLC 5841 CEDAR LAKE RD STE 204 MINNEAPOLIS MN 55416 MANAGEMENT SERVICES 304189 WOLTERS KLUWER 100 S 5TH STREET MINNEAPOLIS MN 55402 JNO SUBSCRIPTIONS 142549 2 61116 61116 ANNUAL SYMPOSIUMS 541900 426835 426835 MEMBERSHIP DUES 541900 268280 268280 JOURNAL OF NEURO-OPHTHALMOLOGY 511120 144169 1620 142549 EDITORIAL SUPPORT 511120 74509 74509 PUBLICATION 511120 4366 4366 918159 74550 74550 MISCELLANEOUS 900099 25186 25186 25186 1079011 800796 0 217099 30000 30000 304189 304189 15398 15398 8170 8170 3135 3135 27650 27650 9116 9116 704 704 110688 110688 1783 1783 JOURNAL 194562 194562 PROJECTS 47215 47215 CME ADMINISTRATION FEES 7550 7550 LEADERSHIP EXPENSE 4190 4190 764350 394205 370145 0 369042 461608 402186 338357 50034 86176 31306 100190 3248 3248 0 0 1560023 1990026 2412591 2976357 3220 18647 15000 5000 329600 468553 347820 492200 X 2045771 2464783 19000 19374 2064771 2484157 2412591 2976357 314661 104725 0 X X 0 1 X 1 0 X 40082 34140 45775 35260 61116 216373 1003617 999744 999811 1010580 918159 4931911 1043699 1033884 1045586 1045840 979275 5148284 0 0 0 5148284 33181 55983 44634 54696 74550 263044 33181 55983 44634 54696 74550 263044 800 9731 13893 15809 25186 65419 1077680 1099598 1104113 1116345 1079011 5476747 0.94000 0.95130 0.04800 0.04070 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2017 AMOUNT: $ 800. 2018 AMOUNT: $ 9,731. 2019 AMOUNT: $ 13,893. 2020 AMOUNT: $ 15,809. 2021 AMOUNT: $ 25,186. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 19000 1314 940 19374 20000 1000 19000 21000 1000 20000 22000 1000 21000 23000 1000 22000 0.00000 0.00000 1.00000 0 0 3248 3248 0 0 X 1183736 104725 104725 1079011 0 1079011 764350 0 764350 0 764350 PART X, LINE 2: FIN 48 DISCLOSURE FROM REVIEWED FINANCIAL STATEMENTS: THE SOCIETY IS CLASSIFIED AS A TAX-EXEMPT ORGANIZATION UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND A SIMILAR SECTION OF THE MINNESOTA STATUTES. THEREFORE, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT INCLUDE A PROVISION FOR INCOME TAXES. THE SOCIETY REVIEWS INCOME TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN INCOME TAX RETURNS TO DETERMINE IF THERE ARE ANY INCOME TAX UNCERTAINTIES. THIS INCLUDES POSITIONS THAT THE ENTITY IS EXEMPT FROM INCOME TAXES OR NOT SUBJECT TO INCOME TAXES ON UNRELATED BUSINESS INCOME. THE SOCIETY RECOGNIZES TAX BENEFITS FROM UNCERTAIN TAX POSITIONS ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITIONS WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES BASED ON THE TECHNICAL MERITS OF THE POSITIONS. THE SOCIETY HAS IDENTIFIED NO SIGNIFICANT INCOME TAX UNCERTAINTIES. THE SOCIETY FILES INFORMATION RETURNS AS A TAX-EXEMPT ORGANIZATION. SHOULD THAT BE CHALLENGED IN THE FUTURE, ALL YEARS SINCE INCEPTION COULD BE SUBJECT TO REVIEW BY THE IRS. 1 LINDSEY DE LOTT MD MS THE REGENTS OF THE UNIVERSITY OF MICHIGAN BOX 223131 PITTSBURGH PA 15251 501(C)(3) 25000 0 RESEARCH 1 PART 1, LINE 2: WRITTEN GRANT APPLICATIONS ARE EVALUATED FOR SPECIFIC QUALIFICATIONS PRIOR TO A GRANT BEING AWARDED BY NANOS. FORM 990, PART VI, SECTION A, LINE 2 DRS. VALARIE BIOUSSE AND NANCY NEWMAN ARE PARTNERS AND SERVE ON THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 3 THE SOCIETY HAS CONTRACTED WITH GLOBAL MANAGEMENT PARTNERS, LLC TO PROVIDE OFFICE SPACE AND ADMINISTRATIVE SERVICES TO THE ORGANIZATION. TRISH SHOMION AND TAMARA OSSIAN, THE ORGANIZATION'S PRIOR AND CURRENT EXECUTIVE DIRECTORS, ARE EMPLOYED BY GLOBAL MANAGEMENT PARTNERS, LLC . DURING THE TAX YEAR ENDED DECEMBER 31, 2021, THE SOCIETY PAID $304,189 TO GLOBAL MANAGEMENT PARTNERS, LLC FOR OFFICE SPACE AND ADMINISTRATION FEES. FORM 990, PART VI, SECTION A, LINE 4 1. THE FOLLOWING NEW PARAGRAPH WAS ADDED TO ARTICLE II - MEMBERSHIP, SECTION 1 - CLASSES OF MEMBERSHIP. THE PROPOSED AMENDMENT WAS APPROVED BY THE NANOS BOARD OF DIRECTORS AND BYLAWS COMMITTEE. NEW PARAGRAPH "CURRENT INTERNATIONAL ACTIVE MEMBERS OR INTERNATIONAL FELLOWS, OR APPLICANTS FOR THESE CLASSES OF MEMBERSHIP, WHO CURRENTLY HOLD BOTH A PERMANENT POSITION (NON-TRAINING) IN THE US OR CANADA AND A FULL AND UNRESTRICTED STATE OR PROVINCIAL LICENSE TO PRACTICE MEDICINE IN THE US OR CANADA, RESPECTIVELY, AND WHO MEET THE REQUIREMENTS DESCRIBED BELOW, MAY REQUEST TO HAVE THEIR MEMBERSHIP CHANGED TO ACTIVE MEMBER OR FELLOW. THE CHANGE WILL BE GRANTED UPON RECOMMENDATION OF THE MEMBERSHIP COMMITTEE AND APPROVAL OF THE BOARD. THIS CHANGE SHALL ENDURE FOR AS LONG AS THE NANOS MEMBER MAINTAINS THEIR POSITION IN THE US OR CANADA." FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS TEN MEMBERSHIP CLASSES, AS DEFINED IN THE ORGANIZATION'S BYLAWS, ARTICLE II. FORM 990, PART VI, SECTION A, LINE 7A FIVE CLASSES OF MEMBERSHIP, AS DETAILED IN THE ORGANIZATION'S BYLAWS, HAVE VOTING RIGHTS AND ELECT THE OFFICERS AND OTHER MEMBERS OF THE EXECUTIVE BOARD. FORM 990, PART VI, SECTION A, LINE 7B ELIGIBLE VOTING MEMBERS MAY AMEND, ALTER, OR REPEAL THE BYLAWS OF THE ORGANIZATION WITH A TWO-THIRDS MAJORITY. FORM 990, PART VI, SECTION B, LINE 11B THE AUDITED FINANCIAL STATEMENTS, UPON WHICH THIS FORM 990 IS BASED, WERE REVIEWED BY THE ORGANIZATION'S TREASURER. THE FORM 990 WILL BE REVIEWED BY THE ORGANIZATION'S ACCOUNTING TEAM, EXECUTIVE DIRECTOR, AND TREASURER BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C PURSUANT TO THE ORGANIZATION'S WRITTEN CONFLICT OF INTEREST DISCLOSURE POLICY, THE NANOS EXECUTIVE COMMITTEE WILL OBTAIN AND CONFIDENTIALLY REVIEW INFORMATION FROM LEADERSHIP AND STAFF ON AN ANNUAL DISCLOSURE REVIEW FORM, AND ALERT THE BOARD OF ANY SERIOUS CONFLICTS. COMPLETION OF THE CONFLICT OF INTEREST DISCLOSURE FORM WILL SATISFY THE DISCLOSURE REQUIREMENTS OF THE POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION DOES NOT HAVE ANY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 INSPECTION IS AVAILABLE BY APPOINTMENT WITH THE GMP PARTNER. FORM 990, PART XII LINE 2C THE ORGANIZATION'S FINANCE COMMITTEE HAS RESPONSIBILITY FOR OVERSIGHT OF THE FINANCIAL REVIEW, SELECTION OF THE INDEPENDENT AUDITOR AND RELATED MATTERS. THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.